14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
AXGN vs KIDS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Axogen, Inc. (AXGN) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXGN carries a Unified Composite Score of 35.3/100 (SELL) at $56.35 (79.7x Forward P/E, -5.2% operating margin), whereas KIDS carries 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin).
Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. AXGN 35.3/100 SELL), AXGN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. -8.2% operating margin) and revenue trajectory (+26.2% vs. +18.6% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXGN vs KIDS. Trailing 12-month operating profitability (AXGN -5.2% vs KIDS -8.2%) and valuation multiples (AXGN 79.7x vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment82.0% of Rev ($217M)
90D Engineering Disclosures0 Published
Investor FAQ AXGN vs KIDS Key Questions & Quantitative Answers
As of Nov 19, 2026, Axogen, Inc. (AXGN) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXGN carries a Unified Composite Score of 35.3/100 (SELL) at $56.35 (79.7x Forward P/E, -5.2% operating margin), whereas KIDS carries 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin). Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. AXGN 35.3/100 SELL), AXGN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. -8.2% operating margin) and revenue trajectory (+26.2% vs. +18.6% YoY).
AXGN leads the Growth & Scale pillar: AXGN posts +26.2% YoY revenue growth and +300.0% YoY earnings growth on $267M TTM revenue (74.2% gross margin, -5.2% operating margin), compared with KIDS at +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin). On trailing 12-month operating scale, AXGN generates $267M in USD-normalized revenue versus $264M for KIDS. In operating R&D and SG&A reinvestment, AXGN deploys 79.4% of Rev ($212M) (0 90-day corporate R&D disclosures) versus 82.0% of Rev ($217M) (0 disclosures) for KIDS.
AXGN screens cheaper on headline valuation multiples. AXGN trades at 79.7x Forward P/E, 125.0x Trailing P/E, N/M PEG, and 11.6x EV/Revenue (7.5% FCF margin), whereas KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AXGN (-10.3% ROE) versus KIDS (-9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, AXGN carries 67.0% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.28β · 121% Vol realized risk). By comparison, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.